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Headache, Blurred Vision and Seizure
in Hemodialysis Patient
A 53-year-old man with severe headache, blurred vision, and single generalized tonic-clonic seizure du-
ring hemodialysis presented to the emergency department (ED). On admission to the ED, the patient was 
in postictal state and measured at the following levels: blood pressure 203/113 mmHg, pulse rate 80/
min, respiratory rate of 17/min, body temperature of 36,5 °C, peripheral O2 saturation of 96%, and GCS 
of 9. Neurologic examination revealed no focal deficit. Bedside finger-stick glucose test was detected at 
59 mg/dl. ECG of the patient was in normal sinus rhythm and revealed no ischemic sign. Intravenous 25 g 
glucose was administered to the patient and control of finger stick glucose test was detected at 281 mg/
dl. However, the mental status of the patient did not improve. The patient had complaints of headache 
and blurred vision for at least one day according to family members. The patient had chronic renal failure 
and hemodialysis for 1.5 years and was on eye drops for glaucoma. On fundoscopic examination, acute 
pathology was not detected. Noncontrast enhanced cranial computerized tomography (CT) was perfor-
med and CT revealed no acute pathology. Laboratory tests of the patient showed creatinin 5.8 and urea 79 
mg/dl and no electrolyte imbalance, leucositosis, or thrombocytopenia. GCS of the patient was detected 
at 14 without focal deficits at two hours after admission to the ED. Contrast enhanced magnetic resonance 
imaging (MRI) of cranial and diffusion MRI was also performed (Figure 1).
Figure 1. The patient’s flair (a) and T2-weighted (b, c) cranial MRI images.
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DIAGNOSIS: Posterior Reversible
Encephalopathy Syndrome
MRI revealed hyperintensity compatible with vaso-
genic edema on FLAIR and t2 weighted sequences 
in the bilateral occipital, parietal, and frontal region 
(Figure 2). After magnetic resonance imaging, the pa-
tient had generalized tonic-clonic seizures. Reduction 
of the patient’s blood pressure from 203/113 mmHg 
to 179/95 mmHg did not cause any clinical improve-
ment. Loading dose of valproic acid was given intra-
venously to the patient. The patient was intubated 
due to uncontrolled seizures and shallow breathing 
and was admitted to intensive care unit. The patient 
died after 6 days due to intracranial hemorrhage.
Posterior reversible encephalopathy syndrome 
(PRES), initially described in 1996 by Hinchey et al., 
is a clinical-neuroradiological entity characterized by 
headache, vomiting, altered mental status, blurred vi-
sion, and seizures.[1] This syndrome is most commonly 
encountered in association with acute hypertensi-
on, preeclampsia or eclampsia, autoimmune disea-
ses, renal failure, post-transplantation, sepsis, shock, 
and exposure to immunosuppressants.[2-4] Although 
the lesions in PRES are due to vasogenic edema, the 
mechanism responsible for the imaging appearance 
remains unclear and controversial.[1,2] There are two 
main hypotheses: 1) Cerebral hypoperfusion related 
to disruption of the blood-brain barrier results in va-
sogenic edema (e.g. eclampsia/preeclampsia, cyclos-
porine toxicity, and infection/sepsis/septic shock), 
and 2) Cerebral hyperperfusion results in vasogenic 
edema by exceeding the capacity for autoregulation 
of perfusion pressure (e.g. acute hypertension).[5] In 
our patient, we considered that hypertension indu-
ced by renal failure led to regional dysautoregulation, 
consequently causing hypoperfusion.
Radiologic findings of PRES are best 
seen on MRI of the brain. The typical 
imaging findings of PRES are most ap-
parent as hyperintensity on FLAIR and 
t2 weighted sequences of cranial MRI in 
the parietooccipital and posterior, fron-
tal, cortical, and subcortical white mat-
ter and are reversible with appropriate 
management.[4,5]
The treatment is based in the manage-
ment or withdrawal of the triggering factor. Hypogl-
ycemia should be looked for routinely and corrected. 
Antiepileptic treatment should be initiated at the 
emergency department. Control of hypertensive 
emergency is an important part of the symptomatic 
management.[1,5] Mortality has been reported in 15% 
of patients. Cause of death in PRES may be due to the 
underlying disease, increased cerebral edema, and 
intracerebral hemorrhage.[6]
The early recognition and treatment of PRES is im-
portant to prevent permanent neurological sequelae. 
Awareness of the clinical and radiographic findings 
of acute PRES is essential to avoid misdiagnosis and 
treatment delay.
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